Page 93 - Read Online

Hakeem et al. Hepatoma Res 2023;9:38 https://dx.doi.org/10.20517/2394-5079.2023.59 Page 13 of 14

differentiation and prognosis. Ann Transplant 2016;21:208-15. DOI
23. Ziogas IA, Giannis D, Economopoulos KP, et al. Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-
regression of survival rates. Transplantation 2021;105:2263-71. DOI
24. Jung DH, Hwang S, Song GW, et al. Clinicopathological features and prognosis of intrahepatic cholangiocarcinoma after liver
transplantation and resection. Ann Transplant 2017;22:42-52. DOI
25. Safdar NZ, Hakeem AR, Faulkes R, et al. Outcomes after liver transplantation with incidental cholangiocarcinoma. Transpl Int
2022;35:10802. DOI PubMed PMC
26. Rayar M, Levi Sandri GB, Houssel-Debry P, Camus C, Sulpice L, Boudjema K. Multimodal Therapy including Yttrium-90
radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma. J
Gastrointestin Liver Dis 2016;25:401-4. PubMed
27. Sapisochin G, Javle M, Lerut J, et al. Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma:
working group report from the ILTS transplant oncology consensus conference. Transplantation 2020;104:1125-30. DOI
28. Akamatsu N, Sakamoto Y, Hasegawa K. Liver transplantation for the solitary intrahepatic cholangiocarcinoma less than 2 cm in
diameter. Hepatobiliary Surg Nutr 2017;6:332-4. DOI PubMed PMC
29. Menon K, Vijayashanker A, Murphy J, et al; NHS Blood and Transplant Liver Transplantation for Colorectal Liver Metastases Fixed
Term Working Group. Liver transplantation for isolated unresectable colorectal liver metastases - protocol for a service evaluation in
the United Kingdom - UKCoMET study. HPB 2023;25:684-92. DOI PubMed
30. NHS blood and transplant. (POL195/14) - liver transplantation: selection criteria and recipient registration. Available from: https://
nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/27372/pol195-120822.pdf [Last accessed on 2 Aug 2023].
31. Liu Y, Wang B, Mo X, Tang K, He J, Hao J. A deep learning workflow for mass-forming intrahepatic cholangiocarcinoma and
hepatocellular carcinoma classification based on MRI. Curr Oncol 2022;30:529-44. DOI PubMed PMC
32. Ni T, Shang XS, Wang WT, Hu XX, Zeng MS, Rao SX. Different MR features for differentiation of intrahepatic mass-forming
cholangiocarcinoma from hepatocellular carcinoma according to tumor size. Br J Radiol 2018;91:20180017. DOI PubMed PMC
33. Jeon Y, Kwon SM, Rhee H, et al. Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma.
Hepatology 2023;77:92-108. DOI
34. Beetz O, Timrott A, Weigle CA, et al. Proposal of a new definition of "very early" intrahepatic cholangiocarcinoma-a retrospective
single-center analysis. J Clin Med 2021;10:4073. DOI PubMed PMC
35. Pillai A. Mixed hepatocellular-cholangiocarcinoma: is it time to rethink consideration for liver transplantation? Liver Transpl
2018;24:1329-30. DOI PubMed
36. Ma KW, Chok KSH, She WH, et al. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or
indication for liver transplantation? a propensity score-matched analysis. Hepatol Int 2018;12:167-73. DOI PubMed
37. Cannella R, Cunha GM, Catania R, et al. Magnetic resonance imaging of nonhepatocellular malignancies in chronic liver disease.
Magn Reson Imaging Clin N Am 2021;29:404-18. DOI
38. Lee DD, Croome KP, Musto KR, et al. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl 2018;24:634-44. DOI
39. Sapisochin G, Ivanics T, Heimbach J. Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time? Hepatology
2022;75:455-72. DOI PubMed
40. Moro A, Mehta R, Sahara K, et al. The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic
cholangiocarcinoma. Ann Surg Oncol 2020;27:2888-901. DOI
41. Wu H, Liang Y, Wang Z, et al. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and
hepatocellular carcinoma. Acta Radiol 2023;64:926-35. DOI
42. Min JH, Lee MW, Park HS, et al. LI-RADS version 2018 targetoid appearances on gadoxetic acid-enhanced MRI: interobserver
agreement and diagnostic performance for the differentiation of HCC and Non-HCC malignancy. AJR Am J Roentgenol 2022;219:421-
32. DOI PubMed
43. Park S, Lee Y, Kim H, et al. Subtype classification of intrahepatic cholangiocarcinoma using liver MR imaging features and its
prognostic value. Liver Cancer 2022;11:233-46. DOI PubMed PMC
44. Ma KW, Cheung TT, Leung B, et al. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic
cholangiocarcinoma: a meta-analysis. Medicine 2019;98:e14013. DOI PubMed PMC
45. Bridgewater J, Fletcher P, Palmer DH, et al; BILCAP study group. Long-term outcomes and exploratory analyses of the randomized
phase III BILCAP study. J Clin Oncol 2022;40:2048-57. DOI
46. Panayotova GG, Guarrera JV, Lunsford KE. Should we reevaluate liver transplantation as an alternative to resection for the treatment
of intrahepatic cholangiocarcinoma? Liver Transpl 2020;26:748-50. DOI PubMed
47. Gül-Klein S, Schmitz P, Schöning W, et al. The role of immunosuppression for recurrent cholangiocellular carcinoma after liver
transplantation. Cancers 2022;14:2890. DOI PubMed PMC
48. Patkowski W, Stankiewicz R, Grąt M, Krasnodębski M, Kornasiewicz O, Krawczyk M. Poor outcomes after liver transplantation in
patients with incidental cholangiocarcinoma irrespective of tumor localization. Transplant Proc 2014;46:2774-6. DOI PubMed
49. NCT02878473- Liver transplantation for early intrahepatic cholangiocarcinoma (LT for iCCA). Available from: https://clinicaltrials.
gov/ct2/show/NCT02878473 [Last accessed on 2 Aug 2023].
50. NCT04195503- Liver transplant for stable advanced intrahepatic cholangiocarcinoma. Available from: https://clinicaltrials.gov/ct2/
show/NCT04195503 [Last accessed on 2 Aug 2023].